Skeletal Metastases in Pancreatic Cancer: A Retrospective Study and Review of the Literature

Background: Skeletal metastases represent an underappreciated site of metastasis in patients with pancreatic cancer. Previous reports have estimated the prevalence to range from 5 percent to 20 percent. With the use of gemcitabine and novel targeted agents such as erlotinib, there has been a modest...

Descripción completa

Detalles Bibliográficos
Autores principales: Borad, Mitesh J., Saadati, Hamid, Lakshmipathy, Arun, Campbell, Elizabeth, Hopper, Patricia, Jameson, Gayle, Von Hoff, Daniel D., Saif, M. Wasif
Formato: Texto
Lenguaje:English
Publicado: Yale Journal of Biology and Medicine 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2660584/
https://www.ncbi.nlm.nih.gov/pubmed/19325940

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2660584/
https://www.ncbi.nlm.nih.gov/pubmed/19325940

Ejemplares similares